Innovating Works
ALLIANCE: Commercialising a smart cardiac implant platform for the treatment of chronic cardiovascular disease AURIGEN MEDICAL LIMITED tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Every year chronic cardiac disease causes 3.9 million deaths in Europe, that’s a death every 8 seconds. Overall chronic cardiac disease is e...
2023-10-24 - 2025-01-31 | Financiado
LAA-START: Left Atrial Appendage Electrical Isolation via Bio photonic Optical Confirmation to Treat Persistent... AURIGEN MEDICAL LIMITED tramitó un H2020: H2020-EIC-FTI-2018-2020 Atrial Fibrillation (AF) is an irregular heartbeat caused by abnormal electrical activity in the heart, that can lead to blood clots with hi...
2018-12-14 - 2022-03-31 | Financiado
AuriGen: Next Generation Left Atrial Appendage Implant to Treat Persistent Atrial Fibrillation AURIGEN MEDICAL LIMITED tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Atrial Fibrillation (AF) is an irregular heartbeat that can lead to blood clots, high risk of stroke and heart failure. AF is caused by abno...
2018-06-26 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.